Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
International Journal of Molecular Sciences
|
September 14, 2024
CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells
Yuta Mitobe, Shuhei Suzuki, Kazuki Nakamura, et al.
International Journal of Molecular Sciences
|
April 13, 2024
The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells
Yurika Nakagawa-Saito, Yuta Mitobe, Keita Togashi, et al.
Anticancer Research
|
October 28, 2025
Efficient Inhibition of FOXM1 Expression and Viability of High-grade Meningioma Cells by Domatinostat-mediated Dual Targeting of HDAC1 and HDAC2
Kazuki Nakamura, Yasufumi Ito, Yurika Nakagawa-Saito, et al.
Journal of Clinical Medicine Research
|
November 15, 2018
Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshi, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells
Senri Takenouchi, Yasufumi Ito, Kazuki Nakamura, et al.
Anticancer Research
|
June 27, 2025
Effective Targeting of Glioma Stem Cells by BSJ-04-122, a Novel Covalent MKK4/7 Dual Inhibitor
Kazuki Nakamura, Yasufumi Ito, Senri Takenouchi, et al.
International Journal of Molecular Sciences
|
August 28, 2025
HDAC Class I Inhibitor Domatinostat Induces Apoptosis Preferentially in Glioma Stem Cells Through p53-Dependent and -Independent Activation of BAX Expression
Yurika Nakagawa-Saito, Yasufumi Ito, Kazuki Nakamura, et al.
Journal of Clinical Medicine Research
|
October 23, 2019
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Experimental and Therapeutic Medicine
|
September 25, 2020
Effect of levocarnitine administration in patients with chronic liver disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Anticancer Research
|
October 28, 2025
Senolytic Elimination of Senescent Ovarian Clear Cell Carcinoma Cells Induced by CEP-1347 With the BH3 Mimetic Navitoclax
Yasufumi Ito, Kazuki Nakamura, Yurika Nakagawa-Saito, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
International Journal of Molecular Sciences
|
September 14, 2024
CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells
Yuta Mitobe, Shuhei Suzuki, Kazuki Nakamura, et al.
International Journal of Molecular Sciences
|
April 13, 2024
The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells
Yurika Nakagawa-Saito, Yuta Mitobe, Keita Togashi, et al.
Anticancer Research
|
October 28, 2025
Efficient Inhibition of FOXM1 Expression and Viability of High-grade Meningioma Cells by Domatinostat-mediated Dual Targeting of HDAC1 and HDAC2
Kazuki Nakamura, Yasufumi Ito, Yurika Nakagawa-Saito, et al.
Journal of Clinical Medicine Research
|
November 15, 2018
Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshi, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells
Senri Takenouchi, Yasufumi Ito, Kazuki Nakamura, et al.
Anticancer Research
|
June 27, 2025
Effective Targeting of Glioma Stem Cells by BSJ-04-122, a Novel Covalent MKK4/7 Dual Inhibitor
Kazuki Nakamura, Yasufumi Ito, Senri Takenouchi, et al.
International Journal of Molecular Sciences
|
August 28, 2025
HDAC Class I Inhibitor Domatinostat Induces Apoptosis Preferentially in Glioma Stem Cells Through p53-Dependent and -Independent Activation of BAX Expression
Yurika Nakagawa-Saito, Yasufumi Ito, Kazuki Nakamura, et al.
Journal of Clinical Medicine Research
|
October 23, 2019
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Experimental and Therapeutic Medicine
|
September 25, 2020
Effect of levocarnitine administration in patients with chronic liver disease
Kazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Anticancer Research
|
October 28, 2025
Senolytic Elimination of Senescent Ovarian Clear Cell Carcinoma Cells Induced by CEP-1347 With the BH3 Mimetic Navitoclax
Yasufumi Ito, Kazuki Nakamura, Yurika Nakagawa-Saito, et al.
Page
of 5